| 摘要 |
<p>This invention provides 1,2,3,4-tetrahydroisoquinoline compounds and their pharmaceutically-acceptable salts, pharmaceutical formulations of said compounds, and methods for treating hyperglycemia associated with non-insulin dependent diabetes and for treating hyperlipidemia.</p> |
